Latest News

Fibrotic hypersensitivity pneumonitis is a chronic and progressive interstitial lung disease, caused by an immune response to inhaled foreign antigens or allergens. Researchers from Yale’s Section of Pulmonary, Critical Care and Sleep Medicine have used single-cell sequencing technology to provide the first high-resolution atlas of this disease, revealing a previously unrecognized immune signature. Their findings were recently published in the American Journal of Respiratory and Critical Care Medicine.

Research shows that exercise can help manage your symptoms and flares. It also strengthens the muscles used for breathing, improves lung function and capacity, and has positive effects on mental health.

The American Thoracic Society (ATS) presented Carolyn Rochester, MD, FCCP, with the Assembly on Pulmonary Rehabilitation Lifetime Achievement Award at the ATS International Conference in late May 2024 in San Diego.

In a new study, published in the American Journal of Respiratory and Critical Care Medicine, researchers used single-cell RNA sequencing to measure the gene expressions of individual peripheral blood mononuclear cells in patients with progressive IPF, patients with stable IPF, and lung-disease-free patients. Previously, the researchers had studied bulk samples of these cells but not examined them individually and in detail.

Naftali Kaminski, MD, Boehringer Ingelheim Pharmaceuticals, Inc. Professor of Medicine and chief of Pulmonary, Critical Care, and Sleep Medicine (Yale-PCCSM), recently partnered with the American Thoracic Society (ATS) to launch a new podcast.

On May 7, 48 staff members from the Department of Internal Medicine were recognized for service anniversaries.

In a Q&A, Changwan "Wonnie" Ryu, MD, MPH, who recently won the ASCI Council Young Physician-Scientist Award, discusses the role of innate immunity in the development of idiopathic pulmonary fibrosis, his goal as a physician-scientist, and the inspiration behind his work.

In October 2023, the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR) honored Carolyn Rochester, MD, FCCP, professor of medicine, with the prestigious Thomas L. Petty Distinguished Pulmonary Scholar Award. The award is presented to an individual “who has made significant advances in the field of pulmonary rehabilitation through research and scholarly contributions and has earned national prominence in the field.”

The new Yale Bronchiectasis and NTM Infections Program at the Winchester Center for Lung Disease specializes in treating patients with chronic respiratory tract infections, including one caused by nontuberculous mycobacteria.